Humana rallies as CMS lifts 2027 Medicare Advantage rates to +2.48%
Humana shares jumped after CMS finalized Medicare Advantage and Part D payment policies for 2027, projecting a 2.48% net average payment increase. The update implies over $13 billion in additional payments to plans versus 2026, easing fears raised by January’s near-flat proposal.
1. What’s moving HUM today
Humana is surging as investors reprice Medicare Advantage profitability after CMS finalized the 2027 Medicare Advantage and Part D Rate Announcement with a projected net average payment increase of 2.48%. The updated rate outlook is materially higher than the near-flat proposal released in January, sparking a broad relief rally across Medicare Advantage-focused insurers. (cms.gov)
2. Why the rate update matters for Humana
Medicare Advantage is central to Humana’s earnings power, so even modest changes in the annual payment update can meaningfully shift expectations for benefit design flexibility, margin stabilization, and pricing posture into the 2027 plan year. CMS framed the 2.48% net increase as reflecting multiple factors, including underlying cost growth, Star Ratings impacts on quality bonus payments, and risk-adjustment updates. (cms.gov)
3. The key fine print investors are watching next
Alongside the higher net payment update, CMS is advancing risk-adjustment policies that can shift the distribution of gains across plans—particularly around treatment of certain chart-review diagnoses—creating potential winners and losers beneath the headline rate number. The market’s next focus is how Humana translates the updated rate environment into 2027 bids, benefits, and membership strategy, while also navigating quality and risk-adjustment dynamics that influence realized payments. (cms.gov)